Posttreatment laparotomy for Hodgkin's disease.

Area of Science:

• Oncology
• Hematology
• Surgical Oncology

Background:

• Hodgkin's disease is a cancer of the lymphatic system.
• Combination chemotherapy is a standard treatment for advanced Hodgkin's disease.
• Assessing remission status is crucial for treatment planning.

Purpose of the Study:

• To evaluate the utility of surgical restaging (posttreatment laparotomy) in patients with stage III and IV Hodgkin's disease.
• To determine the accuracy of clinical remission assessment compared to surgical findings.
• To identify patients who may benefit from further therapy or be spared additional treatment.

Main Methods:

• Twenty-six patients with stage III and IV Hodgkin's disease in apparent remission after chemotherapy underwent surgical restaging.
• Clinical restaging included lymphangiograms and abdominal CT scans.
• Surgical restaging involved posttreatment laparotomy to assess residual disease.

Main Results:

• Eleven patients had concordant normal clinical and surgical restaging.
• Fifteen patients had abnormal clinical restaging (abnormal lymphangiograms or CT scans).
• Two of these 15 patients had confirmed residual Hodgkin's disease in para-aortic nodes and spleen; two relapsed in supradiaphragmatic sites, and no patient with a negative laparotomy recurred abdominally.

Conclusions:

• Restaging laparotomy in selected Hodgkin's disease patients with abnormal imaging can accurately identify residual lymphoma.
• Surgical restaging helps spare patients with no residual disease from further unnecessary therapy.
• This approach can refine treatment strategies and improve patient outcomes with nil mortality or morbidity.